PRAX Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc. is a clinical-stage genetic neuroscience company that develops therapies for patients and families affected by complex and debilitating brain disorders. The company was founded by Kiran Reddy, David Goldstein and Steven Petrou on September 22, 2015 and is headquartered in Cambridge, MA.

$16.76  -1.64 (-8.91%)
As of 11/26/2021 13:00:01 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/15/2020
Outstanding shares:  44,855,777
Average volume:  201,479
Market cap:   $825,346,297
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    74006W108
ISIN:        US74006W1080
Sedol:      BNGFSD8
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   2.51
PS ratio:   0.00
Return on equity:   -45.34%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy